GNOMX CORP. - GNOMX: AREA OF INTEREST NO. 23 HOST-BASED DIAGNOSTICS. THE OVERALL GOAL OF THIS PROJECT IS TO VALIDATE A HOST-BASED DIAGNOSTIC THAT PROVIDES AN IMMUNE DYSREGULATION SCORE TO BE COMPATIBLE WITH A POINT-OF-CARE DEVICE FOR COMMUNITY SETTING USE TO STRAT

On Nov 19, 2025, Department of Health and Human Services obligated $749,700 to GNOMX CORP. for gnomx: area of interest no. 23 host-based diagnostics. the overall goal of this project is to validate a host-based diagnostic that provides an immune dysregulation score to be compatible with a point…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: competed under sap with 100 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in NEW YORK, NY. The contract is scheduled through Oct 30, 2026 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.